TOKYO -- Japanese beverage maker Kirin Holdings plans to begin selling health foods incorporating a proprietary postbiotic bacterial strain in Taiwan in 2025 to curb dependence on its mainstay beer business, Nikkei has learned.
Kirin is launching a product that incorporates Lactococcus lactis strain Plasma (LC-Plasma) -- a type of lactic acid bacterium -- developed with Australian health food maker Blackmores.








.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)